Skip to main content
. 2020 Aug 18;23(12):799–810. doi: 10.1093/ijnp/pyaa061

Figure 1.

Figure 1.

Group differences in global topological properties. AUC, area under curve; CTSZ, clozapine-treated schizophrenia patients; HC, healthy controls; NTSZ, never-treated schizophrenia patients; RTSZ, risperidone-treated schizophrenia patients. An asterisk designates network metrics with significant group differences. *P < .05; **P < .01.